Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2021 Oct 13;9(10):e001387corr1. doi: 10.1136/jitc-2020-001387corr1

Correction: In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity

PMCID: PMC8515422  PMID: 34645672

Jenner AL, Cassidy T, Belaid K, et al. In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity. J Immunother Cancer 2021;9:e001387. doi:10.1136/jitc-2020-001387

This article has been corrected since it first published. The provenance and peer review statement has been added.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES